---
figid: PMC3652374__nihms450079f1
figlink: /pmc/articles/PMC3652374/figure/F1/
number: F1
caption: Insulin signalling attenuates cAMP-mediated lipolysis at multiple steps in
  adipocytes. (a) NPs signal through NP receptor A to increase cGMP levels and activate
  PKG. (b) Stimulation of the β-adrenergic receptor increases cAMP levels, which activates
  PKA. (c) The lipolytic actions of PKA and PKG converge through phosphorylating perilipin-1
  (Plin1), releasing CGI-58 to bind and activate ATGL, thereby stimulating hydrolysis
  of triacylglycerol to DAG. (d) Both PKA and PKG also phosphorylate HSL, inducing
  its translocation to lipid droplets, where it interacts with phosphorylated perilipin
  and acts primarily to convert DAG to MAG. (e) Activation of the insulin receptor–IRS
  signalling pathway inhibits lipolysis through activation of adipose-specific phospholipase
  A2 (AdPLA2), which inhibits adenylate cyclase via prostaglandin E2synthesis, while
  activation of Akt leads to phosphodiesterase 3B (PDE-3B) activation to lower cAMP
  levels. Lipid droplet protein FSP27 is also upregulated by insulin signalling. (f)
  mTORC1 acts as a critical node in the control of adipocyte lipid metabolism, through
  reducing Atgl mRNA levels and (g) stimulating lipogenesis via SREBP1-c. Alternatively,
  mTORC1 stimulates a negative feedback loop through activation of (h) S6K and growth
  factor receptor-bound protein 10 (GRB10). (i) PKA can also regulate adipocyte lipid
  handling by modulating its own activity by phosphorylating and activating PDE-3B,
  while PKA has also been shown to (j) inhibit mTORC1
pmcid: PMC3652374
papertitle: Insulin signalling mechanisms for triacylglycerol storage.
reftext: M. P. Czech, et al. Diabetologia. ;56(5):949-964.
pmc_ranked_result_index: '37952'
pathway_score: 0.9448615
filename: nihms450079f1.jpg
figtitle: Insulin signalling attenuates cAMP-mediated lipolysis at multiple steps
  in adipocytes
year: ''
organisms:
- Homo sapiens
ndex: ace33ef9-defc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3652374__nihms450079f1.html
  '@type': Dataset
  description: Insulin signalling attenuates cAMP-mediated lipolysis at multiple steps
    in adipocytes. (a) NPs signal through NP receptor A to increase cGMP levels and
    activate PKG. (b) Stimulation of the β-adrenergic receptor increases cAMP levels,
    which activates PKA. (c) The lipolytic actions of PKA and PKG converge through
    phosphorylating perilipin-1 (Plin1), releasing CGI-58 to bind and activate ATGL,
    thereby stimulating hydrolysis of triacylglycerol to DAG. (d) Both PKA and PKG
    also phosphorylate HSL, inducing its translocation to lipid droplets, where it
    interacts with phosphorylated perilipin and acts primarily to convert DAG to MAG.
    (e) Activation of the insulin receptor–IRS signalling pathway inhibits lipolysis
    through activation of adipose-specific phospholipase A2 (AdPLA2), which inhibits
    adenylate cyclase via prostaglandin E2synthesis, while activation of Akt leads
    to phosphodiesterase 3B (PDE-3B) activation to lower cAMP levels. Lipid droplet
    protein FSP27 is also upregulated by insulin signalling. (f) mTORC1 acts as a
    critical node in the control of adipocyte lipid metabolism, through reducing Atgl
    mRNA levels and (g) stimulating lipogenesis via SREBP1-c. Alternatively, mTORC1
    stimulates a negative feedback loop through activation of (h) S6K and growth factor
    receptor-bound protein 10 (GRB10). (i) PKA can also regulate adipocyte lipid handling
    by modulating its own activity by phosphorylating and activating PDE-3B, while
    PKA has also been shown to (j) inhibit mTORC1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT3
  - INSR
  - PLA2G16
  - LIPE
  - PRKACB
  - PDE3B
  - PRKAR2A
  - GRB10
  - CIDEC
  - MLST8
  - MAPKAP1
  - AKT2
  - PRKACA
  - PRKG1
  - TG
  - NT5C2
  - PRKAR2B
  - ABHD5
  - MTOR
  - PRKACG
  - PDE5A
  - RICTOR
  - MAG
  - RPTOR
  - MFAP1
  - IRS1
  - PRKAR1A
  - PLIN1
  - PNPLA2
  - PRKAR1B
  - NUCB2
  - MGLL
  - SREBF1
  - glycerol
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: InsR
  symbol: INSR
  source: hgnc_symbol
  hgnc_symbol: INSR
  entrez: '3643'
- word: ADPLA
  symbol: AdPLA
  source: hgnc_alias_symbol
  hgnc_symbol: PLA2G16
  entrez: '11145'
- word: HSL
  symbol: HSL
  source: hgnc_alias_symbol
  hgnc_symbol: LIPE
  entrez: '3991'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PDE-3B
  symbol: PDE3B
  source: hgnc_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: GRB10
  symbol: GRB10
  source: hgnc_symbol
  hgnc_symbol: GRB10
  entrez: '2887'
- word: FSP27
  symbol: Fsp27
  source: hgnc_alias_symbol
  hgnc_symbol: CIDEC
  entrez: '63924'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: TG
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
- word: GMP
  symbol: GMP
  source: hgnc_alias_symbol
  hgnc_symbol: NT5C2
  entrez: '22978'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: CGI-58
  symbol: CGI-58
  source: hgnc_alias_symbol
  hgnc_symbol: ABHD5
  entrez: '51099'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PDE-5A?
  symbol: PDE5A
  source: hgnc_symbol
  hgnc_symbol: PDE5A
  entrez: '8654'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MAG
  symbol: MAG
  source: hgnc_symbol
  hgnc_symbol: MAG
  entrez: '4099'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: Plin1
  symbol: PLIN1
  source: hgnc_symbol
  hgnc_symbol: PLIN1
  entrez: '5346'
- word: ATGL/CGI-58
  symbol: ATGL
  source: hgnc_alias_symbol
  hgnc_symbol: PNPLA2
  entrez: '57104'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: NEFA
  symbol: NEFA
  source: hgnc_alias_symbol
  hgnc_symbol: NUCB2
  entrez: '4925'
- word: MGL
  symbol: MGL
  source: hgnc_alias_symbol
  hgnc_symbol: MGLL
  entrez: '11343'
- word: SREBP1C
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
chemicals:
- word: glycerol
  source: MESH
  identifier: D005990
diseases: []
figid_alias: PMC3652374__F1
redirect_from: /figures/PMC3652374__F1
figtype: Figure
---
